- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00394758
A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia
Comparison of Surgical Procedures in Vulvar and Vaginal Dysplasias
- To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias
- To compare healing related complications, post-operative pain, and scarring between the two procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
First line of treatment for vulvar intraepithelial neoplasia (VIN) and vaginal intraepithelial neoplasia (VAIN) is not well defined. Laser vaporization and ultrasonic surgical aspiration are both accepted surgical modalities used in the treatment of vulvar and vaginal dysplasias, however no prospective study has been done to compare the two procedures. The specific aims of this research study include:
- To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias in a prospective, multi-institutional, randomized clinical trial.
- To compare healing related complications, post-operative pain, and scarring between the two procedures.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- University Hospitals of Cleveland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who present with vulvar or vaginal dysplasias or condylomas that require surgical intervention will be informed of the study by the treating physician
- Pre-operative biopsies to confirm presence of dysplasia / condyloma. Patients with dysplasias of grade 3 / CIS will be included at the discretion of the treating surgeon and will have had invasion confidently excluded by clinical exam and biopsy.
Exclusion Criteria:
- Patients under the age of eighteen or who are pregnant will be excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
recurrence rate
|
Secondary Outcome Measures
Outcome Measure |
---|
side effects
|
pain
|
complications
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vivian von Gruenigen, MD, University Hospitals Cleveland Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASE 4804
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Dysplasia
-
University of Mississippi Medical CenterNot yet recruitingCervical Dysplasia, Uterine | Vaginal Dysplasia | Vulvar Dysplasia
-
Centre Hospitalier Régional d'OrléansCNRS - Pr Chantal PICHONRecruitingPrimary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments (ORGANOIDES)Cervical Cancer | HPV Infection | Vaginal Cancer | Cervical DysplasiaFrance
-
Shanghai Bovax Biotechnology Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.CompletedVulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | AIS | Invasive Carcinoma | Cervical Cancers | CIN 3 | Vin III | Mild Dysplasia of Vulva | Moderate Dysplasia of VulvaChina
-
University of LouisvilleCompletedPhysical Activity | Surgery | Vaginal Hysterectomy | Vaginal SurgeryUnited States
-
El-Galaa Military Medical ComplexCompletedVaginal Infection | Vaginal Cuff Dehiscence | Vaginal HematomaEgypt
-
Northwell HealthMayo Clinic; NinePoint MedicalCompletedBarrett's Esophagus Without Dysplasia | Barrett's Esophagus With Dysplasia | Barrett's Esophagus With Low Grade Dysplasia | Barrett's Esophagus With High Grade Dysplasia | Barrett's Esophagus With Dysplasia, UnspecifiedUnited States
-
Hadassah Medical OrganizationRecruitingVaginal Flora Imbalance | Human Papilloma Virus | Cancer Cervix Uterus | Cervical DysplasiaIsrael
-
Assiut UniversityUnknown
-
Universita degli Studi di CataniaProBioEtnaCompleted
-
Joaquín Moya-Angeler Pérez-MateosRecruitingTROCLEAR DYSPLASIASpain
Clinical Trials on CO2 laser surgery
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedHead and Neck CancerUnited States
-
Azienda Ospedaliero-Universitaria CareggiCompletedDiabetic Foot Ulcer
-
Assiut UniversityNot yet recruitingAtrophic Scar
-
Xuekui LiuFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital... and other collaboratorsRecruitingSquamous Cell Carcinoma of GlottisChina
-
Lumenis Be Ltd.Completed
-
Cairo UniversityNot yet recruiting
-
Marta Hemmingson-Van BeekCompleted
-
Assiut UniversityUnknown
-
Rambam Health Care CampusActive, not recruiting
-
Kaplan Medical CenterUnknown